274 related articles for article (PubMed ID: 27760195)
1. Prolyl Oligopeptidase Inhibition Attenuates Steatosis in the L02 Human Liver Cell Line.
Zhou D; Li BH; Wang J; Ding YN; Dong Y; Chen YW; Fan JG
PLoS One; 2016; 11(10):e0165224. PubMed ID: 27760195
[TBL] [Abstract][Full Text] [Related]
2. Inhibitory effect of schisandrin B on free fatty acid-induced steatosis in L-02 cells.
Chu JH; Wang H; Ye Y; Chan PK; Pan SY; Fong WF; Yu ZL
World J Gastroenterol; 2011 May; 17(19):2379-88. PubMed ID: 21633637
[TBL] [Abstract][Full Text] [Related]
3. [Effects of farnesoid X receptor on lipid metabolism in L02 cells].
Hong JL; Shen W; Bai MJ
Zhonghua Gan Zang Bing Za Zhi; 2008 Dec; 16(12):935-9. PubMed ID: 19105941
[TBL] [Abstract][Full Text] [Related]
4. Liraglutide reduces lipid accumulation in steatotic L‑02 cells by enhancing autophagy.
Zhou SW; Zhang M; Zhu M
Mol Med Rep; 2014 Nov; 10(5):2351-7. PubMed ID: 25230688
[TBL] [Abstract][Full Text] [Related]
5. Hugan Qingzhi medication ameliorates hepatic steatosis by activating AMPK and PPARα pathways in L02 cells and HepG2 cells.
Yin J; Luo Y; Deng H; Qin S; Tang W; Zeng L; Zhou B
J Ethnopharmacol; 2014 May; 154(1):229-39. PubMed ID: 24735863
[TBL] [Abstract][Full Text] [Related]
6. [Huazhi Rougan Granules attenuates steatosis in cell model of nonalcoholic fatty liver disease by inducing autophagy].
Shi YM; Fu ZH; Zhu CS; Li XP
Zhongguo Zhong Yao Za Zhi; 2023 Apr; 48(7):1770-1778. PubMed ID: 37282951
[TBL] [Abstract][Full Text] [Related]
7. Xiaoyao San attenuates hepatic steatosis through estrogen receptor α pathway in ovariectomized ApoE-/- mice.
Hu T; Wei M; Hong G; Qi T; Xiang Y; Yang Y; Yi Y
J Ethnopharmacol; 2022 Jan; 282():114612. PubMed ID: 34496266
[TBL] [Abstract][Full Text] [Related]
8. Differential effect of oleic and palmitic acid on lipid accumulation and apoptosis in cultured hepatocytes.
Ricchi M; Odoardi MR; Carulli L; Anzivino C; Ballestri S; Pinetti A; Fantoni LI; Marra F; Bertolotti M; Banni S; Lonardo A; Carulli N; Loria P
J Gastroenterol Hepatol; 2009 May; 24(5):830-40. PubMed ID: 19207680
[TBL] [Abstract][Full Text] [Related]
9. Prolyl oligopeptidase attenuates hepatic stellate cell activation through induction of Smad7 and PPAR-γ.
Zhou D; Wang J; He LN; Li BH; Ding YN; Chen YW; Fan JG
Exp Ther Med; 2017 Feb; 13(2):780-786. PubMed ID: 28352366
[TBL] [Abstract][Full Text] [Related]
10. [Establishment and optimization of hepatocyte steatosis model].
Gao JX; Li XJ; Zhang W; Li YS; Tang HB
Zhonghua Gan Zang Bing Za Zhi; 2018 Dec; 26(12):922-926. PubMed ID: 30669785
[No Abstract] [Full Text] [Related]
11. Compound K modulates fatty acid-induced lipid droplet formation and expression of proteins involved in lipid metabolism in hepatocytes.
Kim MS; Lee KT; Iseli TJ; Hoy AJ; George J; Grewal T; Roufogalis BD
Liver Int; 2013 Nov; 33(10):1583-93. PubMed ID: 23998390
[TBL] [Abstract][Full Text] [Related]
12. Effect of miRNA-10b in regulating cellular steatosis level by targeting PPAR-alpha expression, a novel mechanism for the pathogenesis of NAFLD.
Zheng L; Lv GC; Sheng J; Yang YD
J Gastroenterol Hepatol; 2010 Jan; 25(1):156-63. PubMed ID: 19780876
[TBL] [Abstract][Full Text] [Related]
13. [SREBP-1c knockdown attenuated fatty degeneration in hepatic L02 cells and inhibited CCL2 and FGF21 protein expression].
Wang WD; Wang J; Fan LL; Xiong J; Sun WJ; Hu L; Yang L; Chen DF
Zhonghua Gan Zang Bing Za Zhi; 2011 Sep; 19(9):664-9. PubMed ID: 22152380
[TBL] [Abstract][Full Text] [Related]
14. PPAR agonists reduce steatosis in oleic acid-overloaded HepaRG cells.
Rogue A; Anthérieu S; Vluggens A; Umbdenstock T; Claude N; de la Moureyre-Spire C; Weaver RJ; Guillouzo A
Toxicol Appl Pharmacol; 2014 Apr; 276(1):73-81. PubMed ID: 24534255
[TBL] [Abstract][Full Text] [Related]
15. Prolyl oligopeptidase is involved in release of the antifibrotic peptide Ac-SDKP.
Cavasin MA; Rhaleb NE; Yang XP; Carretero OA
Hypertension; 2004 May; 43(5):1140-5. PubMed ID: 15037553
[TBL] [Abstract][Full Text] [Related]
16. Water Extract of Dolichos lablab Attenuates Hepatic Lipid Accumulation in a Cellular Nonalcoholic Fatty Liver Disease Model.
Im AR; Kim YH; Lee HW; Song KH
J Med Food; 2016 May; 19(5):495-503. PubMed ID: 27152979
[TBL] [Abstract][Full Text] [Related]
17. Lipid Regulation Effects of Raw and Processed Notoginseng Radix Et Rhizome on Steatotic Hepatocyte L02 Cell.
Chen Z; Li C; Yang C; Zhao R; Mao X; Yu J
Biomed Res Int; 2016; 2016():2919034. PubMed ID: 27642594
[TBL] [Abstract][Full Text] [Related]
18. The prolyl oligopeptidase inhibitor SUAM-14746 attenuates the proliferation of human breast cancer cell lines in vitro.
Tanaka S; Suzuki K; Sakaguchi M
Breast Cancer; 2017 Sep; 24(5):658-666. PubMed ID: 28070831
[TBL] [Abstract][Full Text] [Related]
19. [Comparison of effects of oleic acid and palmitic acid on lipid deposition and mTOR / S6K1 / SREBP-1c pathway in HepG2 cells].
Zhou YP; Wu R; Shen W; Yu HH; Yu SJ
Zhonghua Gan Zang Bing Za Zhi; 2018 Jun; 26(6):451-456. PubMed ID: 30317760
[No Abstract] [Full Text] [Related]
20. Microarray analyses and molecular profiling of steatosis induction in immortalized human hepatocytes.
De Gottardi A; Vinciguerra M; Sgroi A; Moukil M; Ravier-Dall'Antonia F; Pazienza V; Pugnale P; Foti M; Hadengue A
Lab Invest; 2007 Aug; 87(8):792-806. PubMed ID: 17558421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
